Skip to main content
. Author manuscript; available in PMC: 2010 Sep 15.
Published in final edited form as: Clin Cancer Res. 2009 Sep 1;15(18):5937–5944. doi: 10.1158/1078-0432.CCR-08-3282

Figure 1.

Figure 1

T cell proliferation data for (A) BA7072 and (B) HER500 at 10 µg/mL. Interferon gamma (IFN-γ;) enzyme-linked immunospot (ELISPOT) data for (C) BA7072 and (D) HER500 at 10 µg/mL. Data are shown for each sample. Median response for each time point is indicated by the line. Orange, purple, and green marks represent breast, colon, and ovarian cancer patients, respectively. P-values associated with the change at each week from baseline were calculated using the Wilcoxon signed rank test.